IPCALAB:NSEIPCA Laboratories Limited Analysis

Ipca Laboratories Limited trades at INR 1,972.10, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it gained 12.1%. Relative strength is 65.0 — approaching overbought — and the MACD signal is bearish. Recent trading has carved out support near INR 1,720.00 and resistance around INR 2,001.50.
Multiples put this in overvalued territory: 38.3 times earnings against the sector's 29.8. Revenue is growing at 20.8% on a 12.9% profit margin. The 0.31% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 34.5%, a beta of -0.29 and a maximum drawdown of 12.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.